145 related articles for article (PubMed ID: 25721753)
1. Radiotherapy with rituximab as first-line treatment for early-stage follicular lymphoma.
Cencini E; Fabbri A; Schiattone L; Bartalucci G; Bocchia M
Leuk Lymphoma; 2015; 56(10):2997-8. PubMed ID: 25721753
[No Abstract] [Full Text] [Related]
2. Stage I-II follicular lymphoma: an endangered species?
McLaughlin P; Seymour JF
Leuk Lymphoma; 2015; 56(8):2229-30. PubMed ID: 26397239
[No Abstract] [Full Text] [Related]
3. Radiotherapy with rituximab may be better than radiotherapy alone in first-line treatment of early-stage follicular lymphoma: is it time to change the standard strategy?
Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
Leuk Lymphoma; 2015; 56(8):2350-6. PubMed ID: 25426666
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy plus rituximab as first-line regimen for localized follicular lymphoma.
Cencini E; Puccini B; Rigacci L; Fabbri A; Kovalchuk S; Mannelli L; Benelli G; Carfagno T; Simontacchi G; Bocchia M; Bosi A
Leuk Lymphoma; 2018 Jun; 59(6):1420-1426. PubMed ID: 28994343
[TBL] [Abstract][Full Text] [Related]
5. Patients with relapsed follicular lymphoma treated with rituximab versus tositumomab and iodine I-131 tositumomab.
Quackenbush RC; Horner TJ; Williams VC; Giampietro P; Lin TS
Leuk Lymphoma; 2015 Mar; 56(3):779-81. PubMed ID: 24898665
[No Abstract] [Full Text] [Related]
6. [Current treatment strategies for follicular lymphoma].
Hiddemann W; Hoster E; Schmidt C; Dreyling M; Unterhalt M
Internist (Berl); 2016 Mar; 57(3):222-9. PubMed ID: 26842683
[TBL] [Abstract][Full Text] [Related]
7. The role of "watch and wait" in intestinal follicular lymphoma in rituximab era.
Tari A; Asaoku H; Takata K; Fujimori S; Tanaka S; Fujihara M; Koga T; Yoshino T
Scand J Gastroenterol; 2016 Mar; 51(3):321-8. PubMed ID: 26382560
[TBL] [Abstract][Full Text] [Related]
8. Primary Duodenal Follicular Lymphoma Treated With Rituximab Monotherapy and Followed-up for 15 Years.
Seki A; Iwamuro M; Yoshioka M; Fujii N; Okada H; Nose S; Takata K; Yoshino T; Yamamoto K
Acta Med Okayama; 2015; 69(5):301-6. PubMed ID: 26490027
[TBL] [Abstract][Full Text] [Related]
9. Is There a Best Initial Treatment for a New Patient With Low Grade Follicular Lymphoma.
Jacobson CA; Freedman AS
Curr Hematol Malig Rep; 2016 Jun; 11(3):218-23. PubMed ID: 26995595
[TBL] [Abstract][Full Text] [Related]
10. [Malignant B-Cell Lymphoma: Advances in the Therapy of Follicular Lymphoma and Mantle-cell Lymphoma].
Buske C; Dreyling M
Dtsch Med Wochenschr; 2018 Jan; 143(1):46-51. PubMed ID: 29316585
[No Abstract] [Full Text] [Related]
11. Primary follicular lymphoma of the cervix uteri: a review.
Korcum AF; Karadogan I; Aksu G; Aralasmak A; Erdogan G
Ann Hematol; 2007 Sep; 86(9):623-30. PubMed ID: 17583814
[TBL] [Abstract][Full Text] [Related]
12. Symptoms and toxicity of rituximab maintenance relative to observation following immunochemotherapy in patients with follicular lymphoma.
Zhou X; Wang J; Zhang J; Copley-Merriman C; Torigoe Y; Reyes C; Seymour JF; Offner FC; Trneny M; Salles GA
Hematology; 2015 Apr; 20(3):129-36. PubMed ID: 25029908
[TBL] [Abstract][Full Text] [Related]
13. Impact of rituximab maintenance and maintenance schedule on prognosis in first-line treatment of follicular lymphoma. Retrospective analysis from Czech Lymphoma Study Group (CLSG) database.
Janikova A; Bortlicek Z; Campr V; Kopalova N; Benesova K; Hamouzova J; Belada D; Prochazka V; Pytlik R; Vokurka S; Pirnos J; Duras J; Mocikova H; Mayer J; Trneny M
Leuk Lymphoma; 2016 May; 57(5):1094-103. PubMed ID: 26293000
[TBL] [Abstract][Full Text] [Related]
14. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow infiltration of CD20-negative follicular lymphoma after rituximab therapy: a histological mimicker of hematogones and B-cell acute lymphoblastic leukemia/lymphoma.
Matsuda I; Hirota S
Int J Clin Exp Pathol; 2015; 8(8):9737-41. PubMed ID: 26464748
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of follicular lymphoma: an update.
Bargetzi M; Baumann R; Cogliatti S; Dietrich PY; Duchosal M; Goede J; Hitz F; Konermann C; Lohri A; Mey U; Novak U; Papachristofilou A; Stenner F; Taverna C; Zander T; Renner C
Swiss Med Wkly; 2018; 148():w14635. PubMed ID: 30044476
[TBL] [Abstract][Full Text] [Related]
17. What is the optimal management of early-stage low-grade follicular lymphoma in the modern era?
Vargo JA; Gill BS; Balasubramani GK; Beriwal S
Cancer; 2015 Sep; 121(18):3325-34. PubMed ID: 26042364
[TBL] [Abstract][Full Text] [Related]
18. Primary conjunctival follicular lymphoma treated with the anti-CD20 antibody rituximab and low-dose involved-field radiotherapy.
Takahira M; Okumura H; Minato H; Urushisaki N; Sakurai M; Sugiyama K
Jpn J Ophthalmol; 2007; 51(2):149-51. PubMed ID: 17401629
[No Abstract] [Full Text] [Related]
19. What is the role of stem-cell transplantation for follicular non-hodgkin lymphoma in the rituximab era?
Schouten HC
J Clin Oncol; 2013 May; 31(13):1617-8. PubMed ID: 23547074
[No Abstract] [Full Text] [Related]
20. First-line obinutuzumab for follicular lymphoma.
Baker H
Lancet Oncol; 2017 Nov; 18(11):e648. PubMed ID: 29033196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
